The Canada Cosmetic Ingredient Hotlist is an essential regulatory document developed and updated by Health Canada, serving as a reference for ingredients that are either prohibited or restricted in cosmetics sold in Canada.The Hotlist is a key component of the Cosmetic Regulations under the Food and Drugs Act (FDA) and the Cosmetic Regulations (CR) of Canada.
The Hotlist includes approximately 500 entries of ingredients which are considered and divided into two distinct lists, one for ingredients identified as being prohibited and another for those identified as being restricted.
List of Ingredients that are Prohibited for Use in Cosmetic Products
The List of Ingredients that are Prohibited for Use in Cosmetic Products: including synonyms, salts and related compounds, should not be present in cosmetic products sold in Canada.
List of Ingredients that are Restricted for Use in Cosmetic Products
The List of Ingredients that are Restricted for Use in Cosmetic Products: including restricted ingredients that are permitted only if the conditions of use and/or cautionary statement(s) are met as outlined.
üIf the ingredient has a concentration restriction, providing the exact concentration used in the product at the time of notification will help expedite processing of the Cosmetic Notification Form.
Tips：
lThe Hotlist pertains to substances that are intentionally added to cosmetics. It is not meant to cover common and pervasive impurities and/or contaminants (e.g. heavy metals) that may be present at trace levels in a finished product.
lIngredients on the Hotlist are set out in alphabetical order. Please be aware of discrepancies between nomenclature, as one substance may have several synonyms. Whenever possible, ingredients on the Hotlist will appear under International Nomenclature of Cosmetic Ingredients (INCI) form, followed by a Chemical Abstracts Service number (CAS#). In the case that an INCI name or CAS # does not exist, ingredients may be listed by one of the following:
üLatin name
üInternational Non-Proprietary Names (INN) recommended by the World Health Organization
üEuropean or U.S. Pharmacopoeia name
üInternational Union of Pure and Applied Chemistry (IUPAC) name or Chemical Abstracts Service (CAS) name
üCommon name
